Australian Pancreatic Genome Initiative

The Australian Pancreatic Cancer Genome Initiative (APGI) is a member of the International Cancer Genome Consortium (ICGC), a worldwide collaborative effort to comprehensively catalogue the genomic and transcriptomic abnormalities in over 50 major human cancers. Pancreatic Cancer was named as Australia’s major contribution to the ICGC, and the work of the APGI is providing unprecedented new insights into the molecular biology of pancreatic cancer, and helping promote research in development of new cancer treatments that are tailored towards individual patients.

The APGI brings together expertise of pancreatic cancer scientists and health professionals across 15 clinical sites and academic institutions in Australia, and is dedicated to improving outcomes for pancreatic cancer patients and their families. 

In the News

Diseases We Research
Pancreatic Cancer

Loading jobs...